Skip to main content
MedPathMedPath Home
Clinical Trials/2022-502872-22-00
2022-502872-22-00
Completed
Phase 1

A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the Effect of Food on the Bioavailability of Ritlecitinib Intact Blend-In Capsule in Healthy Adult Participants.

Pfizer Inc.1 site in 1 country12 target enrollmentStarted: March 20, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Status
Completed
Enrollment
12
Locations
1
OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 65+ years (18-64 Years, 65+ Years)
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Clinical Medical Lead

Scientific

Pfizer Inc.

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
NCT07272330Shandong Suncadia Medicine Co., Ltd.38
Completed
Phase 1
A Phase 1 Study of Two PRN1008 Tablet Formulations and the impact of Midazolam and Famotidine on PRN1008 in Healthy Subjects
ACTRN12618000249257Principia Biopharma Inc14
Active, not recruiting
Not Applicable
A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteersHuman Immunodeficiency Virus (HIV-1) InfectionMedDRA version: 17.1Level: LLTClassification code 10020192Term: HIV-1System Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2015-000725-37-Outside-EU/EEAGilead Sciences, Inc.78
Active, not recruiting
Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-9545 Alone or in Combination with Palbociclib and/or LHRH Agonist in Patients with Locally Advanced or Metastatic Estrogen Receptor−Positive Breast Cancer
2023-506700-12-00Genentech Inc.45
Completed
Phase 1
A proof of concept study comparing the skin penetration abilities of the novel penetration enhancer Tocopheryl Phosphate Mix (TPM)/Diclofenac compared with Voltaren GelTransdermal drug deliveryMusculoskeletal conditionsMusculoskeletal - Other muscular and skeletal disordersMusculoskeletal - Osteoarthritis
ACTRN12608000574347Phosphagenics Limited12